Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography

David S. Barber, Jason Hunt, Richard M. LoPachin, Marion Ehrich

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Acrylamide is a widely used monomer that produces peripheral neuropathy. It is metabolized to the epoxide, glycidamide, which is also considered to be neurotoxic. A new reversed-phase high-performance liquid chromatography (HPLC) method is described that permits simultaneous determination of acrylamide and glycidamide in rat plasma. Samples were deproteinized with acetonitrile and chromatography was performed using isocratic elution and UV absorption detection. The limits of detection for acrylamide and glycidamide were 0.05 and 0.25 μg/ml in plasma, respectively, and recovery of both analytes was greater than 90%. The assay was linear from 0.1 to 100 μg/ml for acrylamide and from 0.5 to 100 μg/ml for glycidamide. Variation over the range of the standard curve was less than 15%. The method was used to determine the concentration - time profiles of acrylamide and glycidamide in the plasma of acrylamide-treated rats.

Original languageEnglish (US)
Pages (from-to)289-293
Number of pages5
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume758
Issue number2
DOIs
StatePublished - Jul 15 2001

Fingerprint

Acrylamide
High performance liquid chromatography
Rats
Plasmas
Epoxy Compounds
Chromatography
glycidamide
Assays
Monomers
Recovery

Keywords

  • Acrylamide
  • Glycidamide

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography. / Barber, David S.; Hunt, Jason; LoPachin, Richard M.; Ehrich, Marion.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 758, No. 2, 15.07.2001, p. 289-293.

Research output: Contribution to journalArticle

@article{40c2d57a29b547db8b5de738f75dd0b1,
title = "Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography",
abstract = "Acrylamide is a widely used monomer that produces peripheral neuropathy. It is metabolized to the epoxide, glycidamide, which is also considered to be neurotoxic. A new reversed-phase high-performance liquid chromatography (HPLC) method is described that permits simultaneous determination of acrylamide and glycidamide in rat plasma. Samples were deproteinized with acetonitrile and chromatography was performed using isocratic elution and UV absorption detection. The limits of detection for acrylamide and glycidamide were 0.05 and 0.25 μg/ml in plasma, respectively, and recovery of both analytes was greater than 90{\%}. The assay was linear from 0.1 to 100 μg/ml for acrylamide and from 0.5 to 100 μg/ml for glycidamide. Variation over the range of the standard curve was less than 15{\%}. The method was used to determine the concentration - time profiles of acrylamide and glycidamide in the plasma of acrylamide-treated rats.",
keywords = "Acrylamide, Glycidamide",
author = "Barber, {David S.} and Jason Hunt and LoPachin, {Richard M.} and Marion Ehrich",
year = "2001",
month = "7",
day = "15",
doi = "10.1016/S0378-4347(01)00191-8",
language = "English (US)",
volume = "758",
pages = "289--293",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "0378-4347",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography

AU - Barber, David S.

AU - Hunt, Jason

AU - LoPachin, Richard M.

AU - Ehrich, Marion

PY - 2001/7/15

Y1 - 2001/7/15

N2 - Acrylamide is a widely used monomer that produces peripheral neuropathy. It is metabolized to the epoxide, glycidamide, which is also considered to be neurotoxic. A new reversed-phase high-performance liquid chromatography (HPLC) method is described that permits simultaneous determination of acrylamide and glycidamide in rat plasma. Samples were deproteinized with acetonitrile and chromatography was performed using isocratic elution and UV absorption detection. The limits of detection for acrylamide and glycidamide were 0.05 and 0.25 μg/ml in plasma, respectively, and recovery of both analytes was greater than 90%. The assay was linear from 0.1 to 100 μg/ml for acrylamide and from 0.5 to 100 μg/ml for glycidamide. Variation over the range of the standard curve was less than 15%. The method was used to determine the concentration - time profiles of acrylamide and glycidamide in the plasma of acrylamide-treated rats.

AB - Acrylamide is a widely used monomer that produces peripheral neuropathy. It is metabolized to the epoxide, glycidamide, which is also considered to be neurotoxic. A new reversed-phase high-performance liquid chromatography (HPLC) method is described that permits simultaneous determination of acrylamide and glycidamide in rat plasma. Samples were deproteinized with acetonitrile and chromatography was performed using isocratic elution and UV absorption detection. The limits of detection for acrylamide and glycidamide were 0.05 and 0.25 μg/ml in plasma, respectively, and recovery of both analytes was greater than 90%. The assay was linear from 0.1 to 100 μg/ml for acrylamide and from 0.5 to 100 μg/ml for glycidamide. Variation over the range of the standard curve was less than 15%. The method was used to determine the concentration - time profiles of acrylamide and glycidamide in the plasma of acrylamide-treated rats.

KW - Acrylamide

KW - Glycidamide

UR - http://www.scopus.com/inward/record.url?scp=0035879918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035879918&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(01)00191-8

DO - 10.1016/S0378-4347(01)00191-8

M3 - Article

C2 - 11486839

AN - SCOPUS:0035879918

VL - 758

SP - 289

EP - 293

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 0378-4347

IS - 2

ER -